Priority Date: 11.07.12 (US 201261670379P)

INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR

  • Application ID: EP13740458
  • Status: EXAMINATION IN PROGRESS

Attorney

no operation time available
Headquarter in London and 5 offices
active in Legal Services and Matchmaking and Trading

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY) Mathys & Squire LLP is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 185 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 11.07.2012 - Priority Date (US 201261670379P)
  • 16.01.2014 - Publication A2 (WO2014011900)
  • 20.05.2015 - Publication A2 (EP2872491)